- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 19/08 - Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
Patent holdings for IPC class A61P 19/08
Total number of patents in this class: 2021
10-year publication summary
|
50
|
92
|
115
|
121
|
116
|
127
|
146
|
136
|
123
|
25
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 644 |
26 |
| Société des Produits Nestlé S.A. | 9938 |
25 |
| Daiichi Sankyo Company, Limited | 1880 |
24 |
| The Regents of the University of California | 20447 |
23 |
| Ascendis Pharma Growth Disorders A/S | 58 |
21 |
| Takeda Pharmaceutical Company Limited | 2722 |
20 |
| Novartis AG | 10463 |
18 |
| BioMarin Pharmaceutical Inc. | 386 |
17 |
| Genzyme Corporation | 1334 |
16 |
| Amgen Inc. | 4318 |
12 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3352 |
12 |
| Megmilk Snow Brand Co., Ltd. | 205 |
11 |
| Keros Therapeutics, Inc. | 71 |
11 |
| Wisconsin Alumni Research Foundation | 3930 |
10 |
| Acceleron Pharma Inc. | 349 |
10 |
| Carna Biosciences, Inc. | 65 |
10 |
| Osaka University | 3334 |
10 |
| Nestec S.A. | 2608 |
9 |
| Centre National de La Recherche Scientifique | 10830 |
9 |
| Kyoto University | 2882 |
9 |
| Other owners | 1718 |